Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer
NCT: NCT06477003 · SUSPENDED
Brief Summary
The purpose of this research is to assess the safety and evaluate the potential of the Multispectral Optoacoustic Tomography (MSOT) device to more precisely identify and assess the neck lymph nodes which might be affected in patients with metastatic head and neck squamous cell carcinomas.
Frequently Asked Questions
What is Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer?
Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer is a clinical trial registered under NCT06477003. Current status: SUSPENDED.
What is the status of NCT06477003?
The current status of NCT06477003 (Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer) is: SUSPENDED.
When did Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer start?
Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer started on 2026-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.